Efficacy and safety of boosted darunavir-based antiretroviral therapy in HIV-1-positive patients: results from a meta-analysis of clinical trials

Darunavir/ritonavir (DRV/r) is a second-generation protease inhibitor used in treatment-naïve and -experienced HIV-positive adult patients. To evaluate efficacy and safety in these patient settings, we performed a meta-analysis of randomized controlled trials. We considered eight studies involving 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Antinori, A., Lazzarin, A., Uglietti, A., Palma, M., Mancusi, D., Termini, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869729/
https://www.ncbi.nlm.nih.gov/pubmed/29588457
http://dx.doi.org/10.1038/s41598-018-23375-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869729/
https://www.ncbi.nlm.nih.gov/pubmed/29588457
http://dx.doi.org/10.1038/s41598-018-23375-6

Ejemplares similares